This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the potential of Verona's ensifentrine on indications including asthma, non cystic fibrosis bronchiectasis and cystic fibrosis

Ticker(s): VRNA

Who's the expert?

Institution: Hurley Medical Center

  • Allergist/Immunologist at Hurley Medical Center.
  • Manages 100 AD patients monthly.
  • Familiar with clinical data investigational therapeutics for HAE

Interview Goal
This conversation will investigate the potential of PDE3/4 inhibition in other indication outside of COPD.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.